Spinal Stabilization Technologies and BlueRiver Acquisition entered into a definitive business combination agreement, according to a July 24 news release.
The combined company will operate under the Spinal Stabilization Technologies name and be listed on the stock exchange. Spinal Stabilization Technologies is known for its lumbar intervertebral disc nucleus replacement device.
The deal is expected to close in the fourth quarter of 2023 or in early 2024. The company would have an estimated $302 million enterprise value post-transaction.
SynerFuse is partnering with Velentium Medical to scale the SynerFuse e-TLIF implant, according to a March 21 news release. Velentium…
Here are four spinal devices that have earned FDA approval, as reported by Becker’s since Jan. 24:
Comments are closed.